source
- Sanofi’s research focus may shift under new CEO Belén Garijo, amid gene therapy advances and telehealth debatesSanofi is entering a period of strategic reassessment as Belén Garijo assumes the chief executive role. Observers are watching to see whether the company will adjust its recent emphasis on immunolo…
- Roche eyes up to $9 billion annual sales from breast cancer pill and obesity drug pipeline amid biosimilar pressureRoche reported first‑quarter earnings that showed a 5% dip in reported revenue, driven by a weaker U.S. dollar against the Swiss franc. On a constant‑currency basis, sales rose 6% to 14.7 billion S…